Jerel A. Banks's most recent trade in Benitec Biopharma Inc was a trade of 2,310,000 Options (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Benitec Biopharma Inc | Jerel A. Banks | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 2,310,000 | 2,310,000 | - | - | Options (right to buy) | |
Benitec Biopharma Inc | Jerel A. Banks | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 466,554 | 466,554 | - | - | Options (right to buy) | |
Benitec Biopharma Inc | Jerel A. Banks | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 356,900 | 356,900 | - | - | Options (right to buy) | |
Benitec Biopharma Inc | Jerel A. Banks | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 284,345 | 284,345 | - | - | Options (right to buy) |